About GSK 219685
This app has been created exclusively for participants in the medical study for GSK 219685. It contains Televisit functionality and allows participants to complete questionnaires.
A seamless Phase 1/2, observer-blind, randomized, placebo-controlled, multicenter study to assess the safety, clinical efficacy and immunogenicity of the UTI vaccine when administered to adults 18 through 64 years of age.
A seamless Phase 1/2, observer-blind, randomized, placebo-controlled, multicenter study to assess the safety, clinical efficacy and immunogenicity of the UTI vaccine when administered to adults 18 through 64 years of age.
GSK 219685 Screenshots
Tap to Rate:
